In big boost to India's COVID-19 battle, Hetero's Tocilizumab biosimilar gets DCGI's nod
The company informed this will enable medical practitioners to use the drug for the treatment of COVID-19 in hospitalised adults who are receiving systemic corticosteroids and require supplemental oxygen.
Sep 06, 2021, 15:13 PM IST
COVID-19: Hetero gets DCGI nod to launch anti-viral drug remdesivir
The company has received the manufacturing and marketing approval for Remdesivir from the Drug Controller General of India (DCGI) for the treatment of COVID-19, it said in a statement.
Jun 21, 2020, 14:38 PM IST
Dr Reddy's to launch Hepatitis C drug in India
Dr Reddy's Laboratories today entered into an agreement with Hetero to distribute and market generic version of US-firm Gilead Sciences' Hepatitis C drug under the brand 'Resof' in India.
Mar 23, 2015, 17:50 PM IST
